Systemic lupus erythematosus
Identifieur interne : 002A18 ( Main/Exploration ); précédent : 002A17; suivant : 002A19Systemic lupus erythematosus
Auteurs :Source :
- Drug and Therapeutics Bulletin [ 0012-6543 ] ; 1996-03.
English descriptors
- Teeft :
- Antiphospholipid, Antiphospholipid syndrome, Arthritis rheum, Azathioprine, Blood pressure, Clinical features, Coronary artery disease, Corticosteroid, Cyclophosphamide, Cytotoxic, Cytotoxic drugs, Disease activity, Dos, Erythematosus, Haemolytic anaemia, Hydroxychloroquine, Inflammation, Intravenous, Intravenous cyclophosphamide, Lupus, Lupus erythematosus, Lupus nephritis, Mild disease, Neonatal lupus syndrome, Nephritis, Nsaid, Oral cyclophosphamide, Organ involvement, Prednisolone, Prednisolone dose, Pulse cyclophosphamide, Rash, Regimen, Remission, Renal, Renal failure, Renal function, Rheum, Severe inflammation, Severe lupus nephritis, Severe nephritis, Spontaneous abortion, Subacute cutaneous lupus erythematosus, Syndrome, Systemic, Systemic lupus erythematosus, Vital organs.
Abstract
It has been estimated that about 3 in 10 000 people in Britain's cities have systemic lupus erythematosus (SLE)1 and the true figure may be higher.2 Forty years ago, approximately 50% of patients with SLE died within 4 years of diagnosis.3 Prospects have improved with refinements in therapy and the recognition of mild forms of the disease.
Url:
DOI: 10.1136/dtb.1996.34320
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000267
- to stream Istex, to step Curation: 000267
- to stream Istex, to step Checkpoint: 001808
- to stream Main, to step Merge: 002A70
- to stream Main, to step Curation: 002A18
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Systemic lupus erythematosus</title></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BA23C672ADD0EBF74175D6E074F104FC48697D65</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1136/dtb.1996.34320</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-C702ZJ6Z-N/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000267</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000267</idno><idno type="wicri:Area/Istex/Curation">000267</idno><idno type="wicri:Area/Istex/Checkpoint">001808</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001808</idno><idno type="wicri:Area/Main/Merge">002A70</idno><idno type="wicri:Area/Main/Curation">002A18</idno><idno type="wicri:Area/Main/Exploration">002A18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Systemic lupus erythematosus</title></analytic><monogr></monogr><series><title level="j">Drug and Therapeutics Bulletin</title><title level="j" type="abbrev">DTB</title><idno type="ISSN">0012-6543</idno><idno type="eISSN">1755-5248</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="1996-03">1996-03</date><biblScope unit="volume">34</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="20">20</biblScope></imprint><idno type="ISSN">0012-6543</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0012-6543</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antiphospholipid</term><term>Antiphospholipid syndrome</term><term>Arthritis rheum</term><term>Azathioprine</term><term>Blood pressure</term><term>Clinical features</term><term>Coronary artery disease</term><term>Corticosteroid</term><term>Cyclophosphamide</term><term>Cytotoxic</term><term>Cytotoxic drugs</term><term>Disease activity</term><term>Dos</term><term>Erythematosus</term><term>Haemolytic anaemia</term><term>Hydroxychloroquine</term><term>Inflammation</term><term>Intravenous</term><term>Intravenous cyclophosphamide</term><term>Lupus</term><term>Lupus erythematosus</term><term>Lupus nephritis</term><term>Mild disease</term><term>Neonatal lupus syndrome</term><term>Nephritis</term><term>Nsaid</term><term>Oral cyclophosphamide</term><term>Organ involvement</term><term>Prednisolone</term><term>Prednisolone dose</term><term>Pulse cyclophosphamide</term><term>Rash</term><term>Regimen</term><term>Remission</term><term>Renal</term><term>Renal failure</term><term>Renal function</term><term>Rheum</term><term>Severe inflammation</term><term>Severe lupus nephritis</term><term>Severe nephritis</term><term>Spontaneous abortion</term><term>Subacute cutaneous lupus erythematosus</term><term>Syndrome</term><term>Systemic</term><term>Systemic lupus erythematosus</term><term>Vital organs</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">It has been estimated that about 3 in 10 000 people in Britain's cities have systemic lupus erythematosus (SLE)1 and the true figure may be higher.2 Forty years ago, approximately 50% of patients with SLE died within 4 years of diagnosis.3 Prospects have improved with refinements in therapy and the recognition of mild forms of the disease.</div></front></TEI><affiliations><list></list><tree></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002A18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:BA23C672ADD0EBF74175D6E074F104FC48697D65
|texte= Systemic lupus erythematosus
}}
| This area was generated with Dilib version V0.6.33. |  |